Scope of patient non-adherence to prescribed drug dosing regimens
- At: 2014 FIP Congress in PSWC, Melbourne (Australia)
- Type: Presentation
- By: URQUHART, John (UCSF; MWV Healthcare, Palo alto, United States of America)
Strong evidence and a broad consensus support the conclusion that variable adherence is the leading source of variance in drug response
(1). By 5 years after an initial prescription, the majority of patients initially treated with drugs for chronic diseases have ceased the prescribed treatment. Clinical research has yet to identify a chronic.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.